Wajd Alkabbani

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Topics

Glycemic Control

Systematic Review

Cognitive Impairment

Top Venues

Diabetes, obesity & metabolism

Diabetic medicine : a journal of the British Diabetic Association

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC

This page only lists publications with an associated author ORCID identifier.

Publications

Wajd Alkabbani, Baiju R Shah, Arsène Zongo, Dean T Eurich, Mhd Wasem Alsabbagh, John-Michael Gamble
Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom. Diabetes, obesity & metabolism (2023)
Wajd Alkabbani, Colleen J Maxwell, Kathryn C Fitzgerald, Suzanne L Tyas, Iliana C Lega, John-Michael Gamble
Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes care 46 (2) (2023)
Colleen J Maxwell, Wajd Alkabbani, Sevil Yasar
Pioglitazone and Lower Risk of Dementia: Will This Change Practice? Neurology (2023)
Wajd Alkabbani, Colleen J Maxwell, Kathryn C Fitzgerald, Suzanne L Tyas, Iliana C Lega, John-Michael Gamble
Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes care 46 (2) (2023)
Wajd Alkabbani, Colleen J Maxwell, Kathryn C Fitzgerald, Suzanne L Tyas, Iliana C Lega, John-Michael Gamble
Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study. Diabetes care (2023)
Wajd Alkabbani, Colleen J Maxwell, Kathryn C Fitzgerald, Suzanne L Tyas, Iliana C Lega, John-Michael Gamble
Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunities. Diabetes, obesity & metabolism (2023)
Wajd Alkabbani, Ryan Pelletier, Michael A Beazely, Youssef Labib, Breanna Quan, John-Michael Gamble
Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data. Drug safety 45 (3) (2022)
Wajd Alkabbani, Colleen J Maxwell, Kathryn C Fitzgerald, Suzanne L Tyas, Iliana C Lega, John-Michael Gamble
Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes care (2022)
Wajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, Suzanne L Tyas, Iliana C Lega, John-Michael Gamble
Hypoglycaemia and the risk of dementia: a population-based cohort study using exposure density sampling. International journal of epidemiology (2022)
Wajd Alkabbani, Arsène Zongo, Jasjeet K Minhas-Sandhu, Dean T Eurich, Baiju R Shah, Mhd Wasem Alsabbagh, John-Michael Gamble
Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus. Diabetic medicine : a journal of the British Diabetic Association 39 (8) (2022)
Wajd Alkabbani, John-Michael Gamble
Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date. Drug design, development and therapy 15 (2021)
Wajd Alkabbani, John-Michael Gamble
Active-comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors. British journal of clinical pharmacology (2021)
Wajd Alkabbani, Arsene Zongo, Jasjeet K Minhas-Sandhu, Dean T Eurich, Baiju R Shah, Mhd Wasem Alsabbagh, John-Michael Gamble
Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study. BMJ open diabetes research & care 9 (2) (2021)
Wajd Alkabbani, Kevin J Friesen, Shawn Bugden
Cannabis is legal-why are cannabis-based pharmaceuticals still controlled? Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC 153 (6) (2020)
Ryan Pelletier, Kelvin Ng, Wajd Alkabbani, Youssef Labib, Nicolas Mourad, John-Michael Gamble
The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews. Endocrinology, diabetes & metabolism 3 (3) (2020)
Wajd Alkabbani, Ruth Ann Marrie, Shawn Bugden, Silvia Alessi-Severini, James M Bolton, Paul Daeninck, Christine Leong
Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study. Addiction (Abingdon, England) 114 (10) (2019)